A single-arm, open-label phase II clinical trial of SHR-1210 (camrelizumab) in combination with nimotuzumab in the second-line treatment of advanced esophageal squamous cell carcinoma.

被引：0
|
作者：
Wang, Feng
Xia, Jin
Meng, Xiangrui
Ji, Yinghua
Yang, Xiuli
Hong, Yong-Gui
Wang, Junsheng
Cui, Donghai
Luo, Zhiquan
机构：
[1] Zhengzhou Univ, Affiliated Canc Hosp 1, Henan Canc Hosp, Dept Med Oncol, Zhengzhou, Peoples R China
[2] Anyang Tumor Hosp, Anyang, Henan, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Oncol, Zhengzhou, Peoples R China
[4] Xinxiang Med Univ, Affiliated Hosp 1, Xinxiang, Henan, Peoples R China
[5] Nanyang Med Coll, Affiliated Hosp 1, Nanyang, Peoples R China
[6] Anyang Tumor Hosp, Dept Oncol, Anyang, Henan, Peoples R China
[7] Xinyang Tumor Hosp, Xinyang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16007
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN IN THE FIRST-LINE TREATMENT OF LOCALLY ADVANCED/ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A437 - A437
  • [42] Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
    Lan, Chunyan
    Shen, Jingxian
    Wang, Yin
    Li, Jundong
    Liu, Zhimin
    He, Mian
    Cao, Xinping
    Ling, Jiayu
    Huang, Jiaming
    Zheng, Min
    Zou, Guorong
    Yan, Haowen
    Liu, Qing
    Yang, Fan
    Wei, Wei
    Deng, Yanhong
    Xiong, Ying
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (34)
  • [43] Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial
    Migden, Michael R.
    Khushalani, Nikhil I.
    Chang, Anne Lynn S.
    Lewis, Karl D.
    Schmults, Chrysalyne D.
    Hernandez-Aya, Leonel
    Meier, Friedegund
    Schadendorf, Dirk
    Guminski, Alexander
    Hauschild, Axel
    Wong, Deborah J.
    Daniels, Gregory A.
    Berking, Carola
    Jankovic, Vladimir
    Stankevich, Elizabeth
    Booth, Jocelyn
    Li, Siyu
    Weinreich, David M.
    Yancopoulos, George D.
    Lowy, Israel
    Fury, Matthew G.
    Rischin, Danny
    LANCET ONCOLOGY, 2020, 21 (02): : 294 - 305
  • [44] Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial.
    Lan, Chunyan
    Huang, Xin
    Shen, Jing-Xian
    Wang, Yin
    Xiong, Ying
    Li, Jundong
    Cao, Xinping
    Deng, Yanhong
    He, Mian
    Zou, Guorong
    Wang, Xiaodi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Nimotuzumab in combination with radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma: Results from a prospective, multi-center, open-label, single-arm trial
    Qu, Ang
    Wang, Jun Jie
    Zhuo, Yanhong
    Liu, Zi
    Zhu, Hong
    Wei, Lichun
    Sun, Xiaoge
    Gao, Yuhua
    Cheng, Huijun
    Zhao, Fengju
    Song, Yipeng
    Wen, QingLian
    Zhou, Xiaohong
    Wang, Ping
    Yang, Jialin
    Zou, Lijuan
    Yuan, Xiangkun
    Wu, Dongyue
    He, Jianli
    Zhang, Yun Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Neoadjuvant camrelizumab followed by concurrent camrelizumab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: a single-arm, phase II study
    Sheng, Yinliang
    Meng, Xiangrui
    Zhang, Chunyang
    Shan, Zhengzheng
    Li, Feng
    Wu, Bin
    Xu, Mengli
    Li, Aijia
    Guan, Lulu
    Chen, Lidong
    Sun, Shuzhen
    Ma, Yihui
    Lu, Taiying
    Zhao, Song
    Fan, Qingxia
    Qi, Yu
    Wang, Feng
    JOURNAL OF THORACIC DISEASE, 2024, 16 (08) : 5337 - 5347
  • [47] Update results of anlotinib combined with nab-paclitaxel and cisplatin as neoadjuvant treatment for esophageal squamous cell carcinoma (ESCC): A single-arm, open-label phase II clinical trial
    Zhang, Y-F.
    Li, X-B.
    Hong, Y-G.
    Li, X-M.
    Liang, W-M.
    Zheng, Z-X.
    Yang, G-Y.
    Wen, Y-Y.
    Cao, H.
    Wu, W-L.
    Su, W-Z.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1120 - S1120
  • [48] Sunitinib in Refractory Adrenocortical Carcinoma: A Phase II, Single-Arm, Open-Label Trial
    Kroiss, Matthias
    Quinkler, Marcus
    Johanssen, Sarah
    van Erp, Nielka P.
    Lankheet, Nienke
    Poellinger, Alexander
    Laubner, Katharina
    Strasburger, Christian J.
    Hahner, Stefanie
    Mueller, Hans-Helge
    Allolio, Bruno
    Fassnacht, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (10): : 3495 - 3503
  • [49] Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
    Hu, Zhihuang
    Sun, Si
    Zhao, Xinmin
    Yu, Hui
    Wu, Xianghua
    Wang, Jialei
    Chang, Jianhua
    Wang, Huijie
    ONCOLOGIST, 2022, 27 (04): : 253 - +
  • [50] Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial
    Wang, Xuan
    Wu, Xiaowen
    Yang, Yue
    Xu, Weiran
    Tian, Hui
    Lian, Bin
    Chi, Zhihong
    Si, Lu
    Sheng, Xinan
    Kong, Yan
    Zhou, Li
    Mao, Lili
    Li, Siming
    Tang, Bixia
    Yan, Xieqiao
    Bai, Xue
    Guo, Jun
    Cui, ChuanLiang
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 57 - 65
12345